At Allogene, our mission is to create the next revolution in cancer treatment by advancing allogeneic CAR T therapies, or AlloCARs, directed at blood cancers and solid tumors. With this goal, we are setting out to do something that has never been done before. We recognize that it won’t be easy and will require a lot of hard work, expertise, and dedication. As a team working together, we believe we can make allogeneic CAR T cell therapy a reality for patients and change how cancer is treated.
- We have an experienced, high-performance and growing team of employees whose sole focus is to transform the treatment of cancer.
- We have a deep pipeline of innovative AlloCARs.
- We have an allogeneic platform based on validated gene editing and advanced proprietary cell manufacturing technologies.
- We are on our way to building a culture and a company focused on working collaboratively to do something big for cancer patients.
Our three values – Innovation, Collaboration and Bravery – are core to our organization and how we conduct ourselves every day.
We are rooted in science to find a better solution for treating cancer.
We are one team working together toward the same goal and vision.
We have the courage to take risks and work in the unknown in order to revolutionize the treatment of cancer.